Skip to main content
. 2007 Jul 7;16(7):1137–1146. doi: 10.1007/s11136-007-9219-z

Table 2.

Baseline characteristics of participants (n = 152)

Exercise intervention Vitamin intervention
WP (n = 77) PAP (n = 75) FA/B12/B6 (n = 78) Placebo-pill (n = 74)
Age (Mean (SD)) 75 (2.9) 75 (2.8) 75 (2.8) 75 (2.9)
Gender (% male) 48* 64 56 55
MMSE (Median (10th–90th ‰)) 29 (26–30) 29 (27–30) 29 (25–30) 29 (27–30)
Education (% low/middle/high) 61/22/17 52/29/19 57/26/17 55/26/19
Marital status (% living together) 75 68 69 73
Physical activitya (min/day) (Median (10th–90th ‰)) 44 (10–155) 39 (11–120) 45 (13–155) 38 (9–111)
Vitamin status (% deficient FA/B12/B6)b 46/8/0 48/8/0 49/9/0 45/7/0
Homocysteine statusc (% hyperhomocysteinemia) 27 23 27 23
Blood pressure (% hypertension)d 27* 14 25 16
BMI (kg/m2) (Median (10th–90th p‰)) 26.7 (23.1–31.5) 26.6 (23.5–32.7) 26.5 (23.3–32.8) 26.7 (23.5–31.2)
Smoking (% smokers) 13 15 17 11
Number of self-reported diseases (% 0,1,2)e 52/42/6 69/27/4 66/28/6 55/41/4

WP = Walking Program, PAP = Placebo Activity Program, FA/B12/B6 = Folic Acid, Vitamin B12, Vitamin B6 supplementation, MMSE = Mini Mental State Examination, Education: low = no education, primary education, lower vocational training; intermediate = intermediate level secondary education, intermediate vocational training; high = higher level secondary education, higher vocational training, university training. BMI = Body Mass Index

a ≥3.0 metabolic equivalents

b Cut off points: FA red blood cell <337 nmol/l or FA plasma < 6,3 nmol/l; B12 ≤ 150 pmol/l; B6 < 20 nmol/l

c Homocysteine > 14 mmol/l

d Hypertension = diastole ≥ 90 and systole ≥160

e Cardiovascular disease, chronic obstructive pulmonary disease, diabetes, epilepsy, multiple sclerosis, Parkinson’s disease, psychiatric disease, renal failure requiring dialysis and/or rheumatoid arthritis

* Significantly different from PAP (P < 0.05)